ALS (ALQ) Stock Overview
Engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
ALQ Community Fair Values
Create NarrativeSee what 17 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ALS Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$24.05 |
| 52 Week High | AU$26.17 |
| 52 Week Low | AU$15.97 |
| Beta | 1.16 |
| 1 Month Change | 11.76% |
| 3 Month Change | -2.12% |
| 1 Year Change | 35.95% |
| 3 Year Change | 96.17% |
| 5 Year Change | 98.60% |
| Change since IPO | 4,437.79% |
Recent News & Updates
Narrative Update • May 18
ALQ: Conviction List Inclusion Will Likely Expose Stretch In Future P/E
The analyst price target for ALS has edged up to about A$17.18 from around A$17.10. Analysts cite slightly higher assumptions for revenue growth, profit margins and fair value, along with a lower future P/E and the inclusion of ALS in a key APAC conviction list as support for the updated view.Narrative Update • Apr 29
ALQ: Higher Multiple And Margin Hopes Will Likely Magnify Downside Risk
Analysts have raised their price target on ALS to A$17.10, citing updated assumptions around discount rates, revenue growth, profit margins and forward P/E following recent Street research. Analyst Commentary Recent Street research on ALS reflects a split view, with some highlighting upside based on revised assumptions and others flagging risks around how much optimism is already embedded in the A$17.10 price target.Narrative Update • Apr 13
ALQ: Higher Revenue Hopes And P/E Assumptions Will Likely Expose Downside Risk
Analysts have lifted their price target for ALS to about A$17.10 from roughly A$16.83, citing updated assumptions around revenue growth, profit margins and future P/E multiples following recent research such as the Goldman Sachs upgrade. Analyst Commentary While the latest research has supported a higher price target for ALS, not all commentary is upbeat.Narrative Update • Mar 30
ALQ: Higher Discount Rate Will Likely Pressure P/E And Expose Downside Risk
The updated analyst price target for ALS has moved slightly lower to A$16.83 from A$17.24, as analysts factor in a higher discount rate, while expectations for revenue growth, profit margins and future P/E remain steady. Analyst Commentary Recent research highlights that the lower price target of A$16.83, compared with the prior A$17.24, reflects a more cautious stance on ALS, even as assumptions for revenue growth, margins and future P/E are unchanged.Recent updates
Narrative Update • May 18
ALQ: Conviction List Inclusion Will Likely Expose Stretch In Future P/E
The analyst price target for ALS has edged up to about A$17.18 from around A$17.10. Analysts cite slightly higher assumptions for revenue growth, profit margins and fair value, along with a lower future P/E and the inclusion of ALS in a key APAC conviction list as support for the updated view.Narrative Update • Apr 29
ALQ: Higher Multiple And Margin Hopes Will Likely Magnify Downside Risk
Analysts have raised their price target on ALS to A$17.10, citing updated assumptions around discount rates, revenue growth, profit margins and forward P/E following recent Street research. Analyst Commentary Recent Street research on ALS reflects a split view, with some highlighting upside based on revised assumptions and others flagging risks around how much optimism is already embedded in the A$17.10 price target.Narrative Update • Apr 13
ALQ: Higher Revenue Hopes And P/E Assumptions Will Likely Expose Downside Risk
Analysts have lifted their price target for ALS to about A$17.10 from roughly A$16.83, citing updated assumptions around revenue growth, profit margins and future P/E multiples following recent research such as the Goldman Sachs upgrade. Analyst Commentary While the latest research has supported a higher price target for ALS, not all commentary is upbeat.Narrative Update • Mar 30
ALQ: Higher Discount Rate Will Likely Pressure P/E And Expose Downside Risk
The updated analyst price target for ALS has moved slightly lower to A$16.83 from A$17.24, as analysts factor in a higher discount rate, while expectations for revenue growth, profit margins and future P/E remain steady. Analyst Commentary Recent research highlights that the lower price target of A$16.83, compared with the prior A$17.24, reflects a more cautious stance on ALS, even as assumptions for revenue growth, margins and future P/E are unchanged.
Narrative Update • Mar 16
ALQ: Recent Upgrade And Stable Metrics Will Underpin Future Return Potential
Narrative Update on ALS The consensus analyst price target for ALS remains at A$28.00, with analysts pointing to steady assumptions for revenue growth, profit margins and future P/E, supported by a recent upgrade in Street research sentiment. Analyst Commentary Bullish analysts point to the A$28.00 consensus price target as a signal that the market view on ALS is anchored around steady assumptions for revenue growth, margins and future P/E, with sentiment recently supported by upgraded research.Narrative Update • Mar 02
ALQ: Upgraded Outlook And Earnings Framework Will Shape Future Return Potential
Narrative Update on ALS Analysts have lifted their price target for ALS from A$27.00 to A$28.00, citing updated assumptions for revenue growth, profit margins, and future P/E. These changes are reflected in refreshed valuation inputs.
Narrative Update • Feb 16
ALQ: Future Earnings Assumptions And P/E Expectations Will Support Measured Outlook
Analysts have lifted their A$ fair value estimate for ALS to about A$23.72 from roughly A$22.47, pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations following recent research. Analyst Commentary Bullish Takeaways Bullish analysts view the higher A$23.72 fair value estimate as more in line with updated assumptions on discount rates and future P/E expectations.Analysis Article • Feb 10
Market Participants Recognise ALS Limited's (ASX:ALQ) Revenues
When close to half the companies in the Professional Services industry in Australia have price-to-sales ratios (or...Narrative Update • Feb 02
ALQ: Elevated P/E Assumptions Will Likely Expose Downside Execution Risk
Analysts have lifted their price target on ALS to about A$17.24 from roughly A$12.84, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples following the recent research upgrade. Analyst Commentary Goldman Sachs recently upgraded ALS and lifted their target price to about A$17.24, which sits well above the previous level around A$12.84.Narrative Update • Jan 19
ALQ: Raised FY26 Guidance And Dividend Will Support Higher Future Returns
Analysts have nudged their price target for ALS up by A$1 to A$27, citing slightly adjusted assumptions around fair value, discount rate, revenue growth, profit margin and future P/E to reflect updated expectations. What's in the News ALS raised its fiscal 2026 guidance to target 6% to 8% organic revenue growth, up from 5% to 7%, and is aiming for steady margin improvement in FY26 (Corporate Guidance, Key Developments).Analysis Article • Jan 07
We Think ALS (ASX:ALQ) Can Stay On Top Of Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narrative Update • Jan 05
ALQ: Raised FY26 Guidance And Dividend Will Support Stronger Future Returns
The analyst price target for ALS has been raised from $20.95 to $26.00, as analysts point to slightly stronger expected revenue growth, improved profit margin forecasts, and a higher assumed future P E multiple despite a modest uptick in the discount rate. What's in the News ALS Limited raised its fiscal 2026 guidance, now expecting 6 to 8% organic revenue growth, up from 5 to 7%, alongside steady margin improvement in FY26 (company guidance) The company declared an ordinary interim dividend of AUD 0.194 per share, partially franked to 30%, a 2.6% increase versus the prior comparable period and representing a 55% payout ratio of H1 FY26 underlying NPAT (company announcement) The interim dividend will be paid on 17 December 2025 to shareholders on the register at 27 November 2025, with an ex dividend date of 26 November 2025 (company announcement) Valuation Changes Consensus Analyst Price Target has risen significantly, increasing from A$20.95 to A$26.00.Narrative Update • Dec 15
ALQ: Future Dividend And Margin Trends Will Support Measured Outlook
Analysts have modestly raised their price target for ALS to $22.47 per share, reflecting slightly improved long term assumptions for the discount rate, revenue growth, and profit margin. What's in the News ALS Limited raised its fiscal 2026 guidance, now expecting 6 to 8% organic revenue growth, up from 5 to 7%, with steady margin improvement projected for FY26 (company guidance).Analysis Article • Dec 12
Return Trends At ALS (ASX:ALQ) Aren't Appealing
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Narrative Update • Dec 01
ALQ: Future Margins And Dividend Increase Will Shape Balanced Outlook
Analysts have raised their price target for ALS from $20.51 to $22.47, citing updated forecasts of improved profit margins and a lower discount rate. What's in the News ALS Limited revised its earnings guidance for fiscal year 2026, now projecting 6% to 8% organic revenue growth, an increase from the previous forecast of 5% to 7%, and continued margin improvement (Key Developments).Analysis Article • Nov 24
Shareholders Can Be Confident That ALS' (ASX:ALQ) Earnings Are High Quality
ALS Limited ( ASX:ALQ ) just reported healthy earnings but the stock price didn't move much. Investors are probably...Narrative Update • Nov 17
ALQ: Future Margins And Profitability Will Drive Balanced Outlook
Analysts have increased their price target for ALS from $19.70 to $20.51. They cite improved profit margin forecasts and a slightly higher future price-to-earnings ratio as key drivers behind their more optimistic outlook.Analysis Article • Nov 12
Market Participants Recognise ALS Limited's (ASX:ALQ) Revenues
ALS Limited's ( ASX:ALQ ) price-to-sales (or "P/S") ratio of 3.7x may look like a poor investment opportunity when you...Narrative Update • Nov 01
ALQ: Anticipate Limited Upside as Margins and Revenue Will Modestly Improve
Analysts have raised their price target for ALS from $19.10 to $19.70. They cited improved profit margins and slightly higher revenue growth expectations.Analysis Article • Oct 22
Is It Too Late To Consider Buying ALS Limited (ASX:ALQ)?
ALS Limited ( ASX:ALQ ), is not the largest company out there, but it saw a significant share price rise of 29% in the...Narrative Update • Oct 17
Capitalizing On Environmental Megatrends And PFAS Demand To Fuel Revenue And Margins
Analysts have raised their price target for ALS from $18.40 to $19.10. They cite improvements in projected revenue growth and profit margins as key factors supporting the upgrade.Narrative Update • Oct 03
Capitalizing On Environmental Megatrends And PFAS Demand To Fuel Revenue And Margins
Analysts have raised their price target for ALS from $18.08 to $18.40. This adjustment reflects increased revenue growth expectations, along with a modestly lower discount rate.Analysis Article • Sep 22
Is There An Opportunity With ALS Limited's (ASX:ALQ) 28% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, ALS fair value estimate is AU$27.39 ALS is estimated to be 28...Narrative Update • Sep 09
Capitalizing On Environmental Megatrends And PFAS Demand To Fuel Revenue And Margins
ALS’s marginally lower future P/E signals a slight improvement in valuation sentiment, while revenue growth expectations remain steady, resulting in a modest price target increase from A$17.77 to A$18.08. What's in the News ALS Limited is actively seeking acquisitions but emphasizes a disciplined capital allocation approach, prioritizing acquisitions that meet return hurdles over volume-based targets.Analysis Article • Jun 19
Is There Now An Opportunity In ALS Limited (ASX:ALQ)?
While ALS Limited ( ASX:ALQ ) might not have the largest market cap around , it saw a decent share price growth of 18...Analysis Article • May 24
Is There An Opportunity With ALS Limited's (ASX:ALQ) 29% Undervaluation?
Key Insights The projected fair value for ALS is AU$24.81 based on 2 Stage Free Cash Flow to Equity ALS' AU$17.69 share...
New Narrative • Dec 10
Capitalizing On Environmental Megatrends And PFAS Demand To Fuel Revenue And Margins
Integration and optimization of acquisitions could improve operational efficiency, enhancing margins and earnings over time.Shareholder Returns
| ALQ | AU Professional Services | AU Market | |
|---|---|---|---|
| 7D | 8.3% | 7.9% | 0.08% |
| 1Y | 36.0% | -0.2% | 3.1% |
Return vs Industry: ALQ exceeded the Australian Professional Services industry which returned -0.2% over the past year.
Return vs Market: ALQ exceeded the Australian Market which returned 3.1% over the past year.
Price Volatility
| ALQ volatility | |
|---|---|
| ALQ Average Weekly Movement | 5.7% |
| Professional Services Industry Average Movement | 7.4% |
| Market Average Movement | 10.4% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 4.4% |
Stable Share Price: ALQ has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: ALQ's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1863 | 23,342 | Malcolm Deane | www.alsglobal.com |
ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies.
ALS Limited Fundamentals Summary
| ALQ fundamental statistics | |
|---|---|
| Market cap | AU$12.21b |
| Earnings (TTM) | AU$318.70m |
| Revenue (TTM) | AU$3.32b |
38.3x
P/E Ratio3.7x
P/S RatioIs ALQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALQ income statement (TTM) | |
|---|---|
| Revenue | AU$3.32b |
| Cost of Revenue | AU$2.32b |
| Gross Profit | AU$995.80m |
| Other Expenses | AU$677.10m |
| Earnings | AU$318.70m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 29.99% |
| Net Profit Margin | 9.60% |
| Debt/Equity Ratio | 71.5% |
How did ALQ perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield67%
Payout RatioDoes ALQ pay a reliable dividends?
See ALQ dividend history and benchmarks| ALS dividend dates | |
|---|---|
| Ex Dividend Date | Jun 12 2026 |
| Dividend Pay Date | Jul 03 2026 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 39 days |
Does ALQ pay a reliable dividends?
See ALQ dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/23 09:10 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ALS Limited is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Megan Kirby-Lewis | Barrenjoey Markets Pty Limited |
| Joseph House | Bell Potter |
| Cameron Needham | BofA Global Research |